1 January 2011PatentsAshley Roughton

Patenting life

A case before the Court of Justice for the European Union threatens to radically redraw the patent landscape for embryonic stem cells. Ashley Roughton explains.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

Lululemon's bid to pause ‘Flyknit’ dispute with Nike denied

Court decries Panasonic’s ‘illegitimate’ SEP actions

German court convicts three people of fraud over ‘misleading’ IP invoices

‘Paradise on Earth’: Hangzhou hosts AIPPI’s first China Congress

‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

‘It’s quite unsettling’: How the UPC is changing Europe’s law firms

UPC’s Milan division gears up for ‘unusual case’

Venture capital funding drop of 40% shadows ‘stormy’ global innovation

Patenting life

Editor's picks

Editor's picks

More articles